Publications
Export 6 results:
Filters: Author is Stip, Emmanuel [Clear All Filters]
[Long-acting antipsychotics: The QAAPAPLE algorithm review]. Can J Psychiatry. 2019:706743719847193.
An Exploratory, Open-Label, Randomized Trial Comparing Risperidone Long-Acting Injectable with Oral Antipsychotic Medication in the Treatment of Early Psychosis. Clin Schizophr Relat Psychoses. 2016;9(4):198-208.
[Long-acting injectable antipsychotics: an expert opinion from the Association des médecins psychiatres du Québec]. Can J Psychiatry. 2011;56(6):367-76.
Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia. Am J Drug Alcohol Abuse. 2008;34(1):75-82.
Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy. J Psychopharmacol (Oxford). 2008;22(3):262-9.
Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial. Curr Med Res Opin. 2006;22(7):1277-85.
